Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
Seeking Alpha
Tuesday, October 9, 2012 - 4:21pm
tags:
PLX, Pluristem Therapeutics, Ariad Pharmaceuticals, Ponatinib, Sarepta, eteplirsen, Fabry's disease, Amicus Therapeutics, StemCells
Five Cystic Fibrosis Questions for Vertex Pharma
TheStreet.com
Tuesday, October 9, 2012 - 4:16pm
tags:
cystic fibrosis, Vertex Pharma, Kalydeco, VX-809
Questcor Pharma rises following upgrade
Yahoo/AP
Tuesday, October 9, 2012 - 4:15pm
tags:
Questcor Pharmaceuticals, Acthar
Life Technologies Continues Acquisition Spree
Yahoo/Zacks.com
Tuesday, October 9, 2012 - 4:13pm
tags:
M&A, Life Technologies, Compendia Bioscience, Bristol-Myers Squibb, GSK
4 Reasons To Buy Horizon Pharma
Seeking Alpha
Tuesday, October 9, 2012 - 4:11pm
tags:
Horizon Pharma, Rayos
Why Merck's Earnings Are Outstanding
Motley Fool
Tuesday, October 9, 2012 - 4:10pm
tags:
earnings, Merck
Investing In Cervical Cancer: Merck, Glaxo, And... Inovio?
Seeking Alpha
Tuesday, October 9, 2012 - 11:18am
tags:
cervical cancer, Merck, GSK, Inovio, Sarepta Therapeutics, Synageva
J&J eyes new Doxil process to reverse shortage
Fierce Pharma
Tuesday, October 9, 2012 - 11:16am
tags:
Doxil, JNJ, drug shortages, FDA, EMA
Amarin: The Basics, Pros, Cons, The Whole Scoop
Seeking Alpha
Tuesday, October 9, 2012 - 11:14am
tags:
Amarin, Abbott Labs, GSK
NuPathe to cut half its jobs to conserve cash
Yahoo/Reuters
Tuesday, October 9, 2012 - 10:01am
tags:
NuPathe, layoffs
Lilly's Solanezumab: Did It Actually Work?
Seeking Alpha
Tuesday, October 9, 2012 - 10:00am
tags:
Eli Lilly, solanezumab, Alzheimer's disease
Merck moving its global headquarters as it looks to cut expenses, consolidate properties
Yahoo/AP
Tuesday, October 9, 2012 - 9:59am
tags:
Merck, consolidation
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tuesday, October 9, 2012 - 9:55am
tags:
obesity, Novo Nordisk, Merck, Bristol-Myers Squibb, diabetes, Sanofi
New Promising Data Released on Lilly Alzheimer's Drug
WSJ Online
Tuesday, October 9, 2012 - 9:52am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Impax Sued by Avanir Over Patent for Nuedexta Nerve Drug
Bloomberg
Tuesday, October 9, 2012 - 9:49am
tags:
Impax, Avanir, Nuedexta
Johnson & Johnson's Mishaps Mask A Great Business At A Reasonable Price
Seeking Alpha
Tuesday, October 9, 2012 - 9:49am
tags:
JNJ
Merck Acquires License for Experimental Skin-Patch Immunization
Bloomberg
Tuesday, October 9, 2012 - 9:48am
tags:
Merck, vaccines, Vaxxas, Gardasil, Nanopatch, skin patch
Pfizer Won't Get A Slap On The Wrist From The SEC
Seeking Alpha
Tuesday, October 9, 2012 - 9:47am
tags:
Pfizer, SEC, GSK, JNJ, Merck, Novartis
Lilly Backs Broad Diabetes Range to Challenge Rivals
Bloomberg
Monday, October 8, 2012 - 12:53pm
tags:
Eli Lilly, diabetes, Boehringer Ingelheim, Amylin, LY2605541, GLP-1 agonist, SGLT2 inhibitor
Questcor: Results Of Physician Survey Suggest Increased Sales For Acthar Gel
Seeking Alpha
Monday, October 8, 2012 - 12:49pm
tags:
Acthar, Questcor, MS, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.